Clal Insurance Enterprises Holdings LTD Takeda Pharmaceutical CO LTD Transaction History

Clal Insurance Enterprises Holdings LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$15.03 - $16.32 $41.1 Million - $44.6 Million	-2,733,558 Reduced 98.38%	45,000 $696,000
Q2 2023 Aug 07, 2023	SELL	$15.57 - $17.11 $24.7 Million - $27.2 Million	-1,586,942 Reduced 36.35%	2,778,558 $43.7 Million
Q4 2022 Feb 13, 2023	BUY	$12.42 - $15.62 $310,500 - $390,500	25,000 Added 0.58%	4,365,500 $68.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $33.3 Million - $74.5 Million	2,600,000 Added 149.38%	4,340,500 $56.3 Million
Q2 2022 Aug 09, 2022	BUY	$13.12 - $15.03 $22.8 Million - $26.2 Million	1,740,500 New	1,740,500 $24.4 Million

338

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.